Bita Yazdi Hernandez, MD | |
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
(888) 988-2800 | |
Not Available |
Full Name | Bita Yazdi Hernandez |
---|---|
Gender | Female |
Speciality | Hospice/palliative Care |
Experience | 29 Years |
Location | 441 N Lakeview Ave, Anaheim, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578611471 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | A60908 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital Anaheim Hospice | Tustin, CA | Hospice |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), in which the left ventricle of the heart is not able to relax enough to fill properly with blood, and HF with reduced ejection fraction (HFrEF), in which the left ventricle is not able contract enough to pump out as much blood.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.
Helicobacter pylori, a bacterium found in about 50% of humans worldwide, can cause stomach ulcers and, in extreme cases, gastric cancer. In an article for F1000 Medicine Reports, Seiji Shiota and Yoshio Yamaoka discuss the possible eradication of H. pylori infections
› Verified 1 days ago
Entity Name | Southern California Permanente Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), in which the left ventricle of the heart is not able to relax enough to fill properly with blood, and HF with reduced ejection fraction (HFrEF), in which the left ventricle is not able contract enough to pump out as much blood.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.
Helicobacter pylori, a bacterium found in about 50% of humans worldwide, can cause stomach ulcers and, in extreme cases, gastric cancer. In an article for F1000 Medicine Reports, Seiji Shiota and Yoshio Yamaoka discuss the possible eradication of H. pylori infections
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Bita Yazdi Hernandez, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Bita Yazdi Hernandez, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), in which the left ventricle of the heart is not able to relax enough to fill properly with blood, and HF with reduced ejection fraction (HFrEF), in which the left ventricle is not able contract enough to pump out as much blood.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.
Helicobacter pylori, a bacterium found in about 50% of humans worldwide, can cause stomach ulcers and, in extreme cases, gastric cancer. In an article for F1000 Medicine Reports, Seiji Shiota and Yoshio Yamaoka discuss the possible eradication of H. pylori infections
› Verified 1 days ago
Richard Eugene Hughes, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1300 N. Kraemer Blvd., Anaheim, CA 92806 Phone: 714-630-6363 Fax: 714-630-1921 | |
Michael Salvaggio, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente-orange County, 411 N. Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4594 | |
Abraham Harn, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave Ste 404, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Aleem A Syed, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, Suite 702, Anaheim, CA 92801 Phone: 714-533-0300 Fax: 714-533-0700 | |
Dr. Jagminder Singh Bhalla, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1781 W Romneya Dr, Ste C, Anaheim, CA 92801 Phone: 714-956-3160 Fax: 714-956-1188 | |
Dr. Ashley E. Mires, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, #207, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Hyon Chong Seo, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |